A resurgence in synthetic lethality screening, enabled by CRISPR gene editing, is unlocking targeted drugs for patients with cancerous loss-of-function mutations.

中文翻译：

---

合成杀伤力筛查为新的癌症药物靶标指明了道路

通过CRISPR基因编辑实现的合成致死性筛查的兴起，正在为具有癌症功能丧失突变的患者提供靶向药物。